Therapy Areas: Infectious Diseases
Blacksmith Medicines granted US patent for antibacterial compounds targeting LpxC
2 July 2025 - Blacksmith Medicines Inc, a California-based biopharma company involved in discovering and developing therapeutics targeting metalloenzymes, announced on Tuesday that the United States P...
Seegene launches STAgora infectious disease analytics platform
2 July 2025 - Seegene Inc, a South Korea-based developer of molecular diagnostics (MDx) solutions, announced on Tuesday the launch of STAgora, a next-generation platform for infectious disease analyti...
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results
30 June 2025 - hVIVO plc (AIM:HVO), a specialist in conducting human challenge trials across multiple infectious and respiratory indications, on Monday reported positive topline results from a Phase 2...
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
20 June 2025 - Immuno Cure BioTech, a clinical-stage biotechnology group based in Hong Kong Science Park, announced on Thursday its upcoming collaboration with US-based PharmaJet to evaluate the safet...
Oxurion signs LOI to acquire majority stake in preclinical microbiology CRO
19 June 2025 - Belgian biopharmaceutical company Oxurion NV (Euronext Brussels:OXUR) announced on Thursday that it has signed a letter of intent to acquire 70% of a preclinical microbiology contract r...
bioMérieux acquires Day Zero Diagnostics assets to expand rapid sequencing diagnostics
16 June 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Monday the acquisition of key assets from Day Zero Diagnostics, a US-based infectious disease diagnostics ...